Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Ardea Biosciences, Inc. - Ardea Biosciences and Bayer HealthCare Enter into Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of Cancer
Array BioPharma Inc. - Array BioPharma’s ARRY-520 Demonstrates Significant Activity in Hematological and Taxane-Resistant Tumors
Breast Cancer - Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial
Genta Incorporated - Genta Announces Presentations for Two Lead Compounds, Genasense® and Tesetaxel, at 2009 Annual ASCO Meeting
Synexus - Synexus Ability to Handle the Whole of a Phase II Trial Slashes Time and Costs
Acne Vulgaris - Findings from G. Webster and co-authors provide new insights into acne vulgaris
Adenocarcinoma - Study data from L. Dilauro et al provide new insights into adenocarcinoma
Cancer - Research from Queen's University, National Cancer Institute yields new data on cancer
Cancer - Researchers from National Cancer Institute detail new studies and findings in the area of cancer
Cancer - Studies from A.A. Adjei and co-researchers yield new data on cancer
Cancer - Studies from National Cancer Institute update current data on cancer
Clinical Trial Research - Study data from M.W.J. Ferguson et al provide new insights into clinical trial research
Diabetes - Research from J.L. Selam and co-researchers in the area of diabetes described
Head and Neck Cancer - Data from G. Franchin et al provide new insights into head and neck cancer
Life Sciences - New findings from University of Edinburgh in the area of life sciences published
Melanoma - New melanoma study findings have been reported from Austin Hospital
Multiple Sclerosis - Report summarizes multiple sclerosis study findings from Griffith University
Non-Small Cell Lung Cancer - Researchers from Vanderbilt University describe findings in non-small cell lung cancer
Oral Leukoplakia - Research from University of Texas in the area of oral leukoplakia described
Prostate Cancer - Researchers from Cleveland Clinic provide details of new studies and findings in the area of prostate cancer
Solid Cancer - New findings from R.L. Oostendorp and co-researchers in the area of solid cancer described
Solid Cancer - Recent findings in solid cancer described by D. Hochhauser and colleagues
Squamous Cell Carcinoma - Research conducted by Y.X. Jiang and co-researchers has updated our knowledge about squamous cell carcinoma
Tissue Engineering - New findings from University of Wisconsin in the area of tissue engineering described
Type 1 Diabetes - Researchers' work from Blood Center focuses on type 1 diabetes
Colon Cancer Therapy - Data on colon cancer therapy detailed by researchers at Aichi Cancer Center Hospital
Colon Cancer Therapy - Reports from Hallym University, Department of Internal Medicine add new data to research in colon cancer therapy
Neurology - Researchers from Xijing Hospital, Department of Neurology report recent findings in neurology
Non-Small Cell Lung Cancer Therapy - Reports from Swedish Cancer Institute, Department of Medical Oncology advance knowledge in non-small cell lung cancer therapy
Prostate Cancer Therapy - Data on prostate cancer therapy described by researchers at Massachusetts General Hospital, Division of Hematology-Oncology
Acucela - Acucela Highlights Data to Be Presented at ARVO
Allergies - Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
Anterior Uveitis - Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Anthrax Vaccines - PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
Antigenics Inc. - FDA Grants Orphan Drug Designation to Oncophage for the Treatment of Glioma
Argos Therapeutics, Inc. - Argos Therapeutics Presents Research Validating Feasibility and Safety of its Arcelis™ Personalized Immunotherapy Platform for HIV
Biopharmaceuticals - Safc Biosciences® and Vivalis Collaborate To Optimize Cell Culture Media for Vaccines Production
Celsion Corporation - Celsion Announces First Patient Enrolled in ThermoDox ® Pivotal Phase I/II DIGNITY Trial and Provides an Update on the Recurrent Chest Wall RCW Breast Cancer Program
Cempra Pharmaceuticals - Cempra Pharmaceuticals Inc. Announces Lead Macrolide is Active in vitro Against Clinically Significant Antibiotic-Resistant Pathogenic Organisms
Cystic Fibrosis - Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG
Diabetes - Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Diabetic Neuropathy - Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
Dynavax Technologies Corporation - Dynavax Presents Additional Phase 3 Data for HEPLISAV™ Hepatitis B Vaccine at EASL Medical Conference
Geron Corporation - Geron Presentations on Imetelstat GRN163L at the AACR 2009 Annual Meeting
Halsin Partners - Migraine prevention by targeting glutamate receptors?
Hepatic Encephalopathy - Ocera Therapeutics Presents Data on AST-120 in Patients With Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting
Hepatitis C Virus - Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
HIV/AIDS - ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
Inotek Pharmaceuticals - Inotek Pharmaceuticals’ Novel Glaucoma Candidate, INO-8875, Selected for Presentation at the ARVO 2009 Annual Meeting
Melanoma - Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
Onconova Therapeutics, Inc. - Onconova Therapeutics Announces Presentation of Nonclinical Data on Lead Compound ON 01910.Na and New Jak 2/Bcr-abl Inhibitors at AACR
Pharmaceuticals - Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
Prostate Cancer - Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Prostate Cancer - OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
Prostatic Hyperplasia - Prostate Study Shows BOTOX May Be Safe, Effective Method for Managing Benign Prostatic Hyperplasia
Respiratory Disease - BioMarck Pharmaceuticals Escalates to the Middle Dose of Its Phase 2 Study, and Closes $6.3 Million Series C Financing
SCYNEXIS, Inc. - SCYNEXIS’ SCY-635 Demonstrates Clinically Relevant Single-Agent Results in a Phase 1b Study in Adults with HCV
Seattle Genetics, Inc. - Seattle Genetics Reports Product Development Progress and First Quarter 2009 Financial Results
Sickle Cell Anemia - Sickle Cell Treatment Developed at LA BioMed Approved for Phase 3 Clinical Trial
SuperGen, Inc. - SuperGen Reports 2009 First Quarter Financial Results
Tigris Pharmaceuticals, Inc. - First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418
Tranzyme Pharma - Tranzyme Pharma Announces Positive Phase 2 Results with TZP-101 for Improvement of Symptoms in Patients with Gastroparesis
Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals to Present Data at EASL Suggesting Telaprevir’s Potential for Use in a Broad Range of HCV Patients and Highlighting the Company’s Expanded STAT-C Portfolio
VIA Pharmaceuticals, Inc. - VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
XenoPort, Inc. - Phase II Results for GSK1838262 XP13512 Reported for Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
ZymoGenetics, Inc. - Bristol-Myers Squibb and ZymoGenetics Present Positive 4-week Results of PEG-Interferon lambda with Ribavirin in Hepatitis C
